论文部分内容阅读
目的探讨乳腺癌患者化学治疗对患者的血糖水平的影响。方法对该院2014年1—12月之间的化疗前无糖尿病家族史且血糖正常的182例乳腺癌化疗的患者则进行回顾性分析,有27例患者在化疗后确诊为糖尿病。结果化疗后有82例患者出现血糖升高的临床症状,确诊为糖尿病的患者为27例,血糖范围在7.3~10.9 mmol/L之间,平均(8.4±1.7)mmol/L。结论在对乳腺癌患者进行化疗的过程中要对患者的血糖进行检测,及时发现患者的糖代谢异常,及早的对其进行干预,以保证患者化疗的顺利进行。
Objective To investigate the effect of chemotherapy on the blood glucose level in patients with breast cancer. Methods A retrospective analysis was performed on 182 patients with breast cancer who did not have a family history of diabetes before chemotherapy and whose glycemia was normalized between January and December 2014 in the hospital. Twenty-seven patients were diagnosed with diabetes after chemotherapy. Results Eighty-two patients developed clinical symptoms of hyperglycemia after chemotherapy. Twenty-seven patients were diagnosed with diabetes mellitus, with a mean blood glucose ranged from 7.3 to 10.9 mmol / L with an average of (8.4 ± 1.7) mmol / L. Conclusion In the process of chemotherapy for breast cancer patients to test the blood glucose in patients with timely detection of abnormal glucose metabolism in patients with an early intervention in order to ensure the smooth progress of chemotherapy in patients.